261 related articles for article (PubMed ID: 17168705)
1. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Robak T; Lech-Maranda E; Korycka A; Robak E
Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
[TBL] [Abstract][Full Text] [Related]
2. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.
Robak T; Robak P
Curr Pharm Des; 2012; 18(23):3373-88. PubMed ID: 22591387
[TBL] [Abstract][Full Text] [Related]
3. Older and new purine nucleoside analogs for patients with acute leukemias.
Robak P; Robak T
Cancer Treat Rev; 2013 Dec; 39(8):851-61. PubMed ID: 23566572
[TBL] [Abstract][Full Text] [Related]
4. Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Robak T; Korycka A; Kasznicki M; Wrzesien-Kus A; Smolewski P
Curr Cancer Drug Targets; 2005 Sep; 5(6):421-44. PubMed ID: 16178817
[TBL] [Abstract][Full Text] [Related]
5. Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
Robak T; Korycka A; Lech-Maranda E; Robak P
Molecules; 2009 Mar; 14(3):1183-226. PubMed ID: 19325518
[TBL] [Abstract][Full Text] [Related]
6. Novel purine nucleoside analogues for hematological malignancies.
Korycka A; Lech-Marańda E; Robak T
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
[TBL] [Abstract][Full Text] [Related]
7. Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application.
Korycka A; Błoński JZ; Robak T
Mini Rev Med Chem; 2007 Sep; 7(9):976-83. PubMed ID: 17897085
[TBL] [Abstract][Full Text] [Related]
8. Purine nucleoside analogues in the treatment of myleoid leukemias.
Robak T
Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
[TBL] [Abstract][Full Text] [Related]
9. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.
Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T
Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070
[TBL] [Abstract][Full Text] [Related]
10. Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders.
Robak T; Wierzbowska A; Robak E
Rev Recent Clin Trials; 2006 Jan; 1(1):15-34. PubMed ID: 18393777
[TBL] [Abstract][Full Text] [Related]
11. Nelarabine: a novel purine antimetabolite antineoplastic agent.
Buie LW; Epstein SS; Lindley CM
Clin Ther; 2007 Sep; 29(9):1887-99. PubMed ID: 18035189
[TBL] [Abstract][Full Text] [Related]
12. Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies.
Robak T; Korycka A; Robak E
Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):23-38. PubMed ID: 18221024
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2006 May; 6(5):575-81. PubMed ID: 16719832
[TBL] [Abstract][Full Text] [Related]
14. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
O'Brien S; Kantarjian H; Keating MJ
Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
Johnston JB
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Wilson PK; Szabados E; Mulligan SP; Christopherson RI
Int J Biochem Cell Biol; 1998 Jul; 30(7):833-42. PubMed ID: 9722988
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.
Banti S; Miller PJ; Parker CD; Ananth SL; Horn LL; Babu YS; Sandhu JS
Int Immunopharmacol; 2002 Jun; 2(7):913-23. PubMed ID: 12188033
[TBL] [Abstract][Full Text] [Related]
18. Drug evaluation: forodesine - PNP inhibitor for the treatment of leukemia, lymphoma and solid tumor.
Galmarini CM
IDrugs; 2006 Oct; 9(10):712-22. PubMed ID: 17016779
[TBL] [Abstract][Full Text] [Related]
19. Potential immunological action of purine nucleoside analogues.
Dighiero G
Drugs; 1994; 47 Suppl 6():57-62. PubMed ID: 7525190
[TBL] [Abstract][Full Text] [Related]
20. Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemia.
Balakrishnan K; Ravandi F; Bantia S; Franklin A; Gandhi V
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):458-66. PubMed ID: 23773454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]